Tissue samples from our colorectal cancer patient database also showed that high SYNPO2L expression patients have higher Mesenchymal CAFs Cell Marker levels than low expression patients (Figure 6E, F). The gene discussed is SYNPO2L; the disease is colorectal cancer.